title: Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure.
authors.affiliation: Department of Dermatovenereology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
authors.forename: M
authors.initials: M
authors.lastname: Arenbergerova
authors.affiliation: Department of Oncology and Radiotherapy, Ceske Budejovice Hospital, Ceske Budejovice, Czech Republic.
authors.forename: I
authors.initials: I
authors.lastname: Mrazova
authors.affiliation: Department of Dermatovenereology, Ceske Budejovice Hospital, Ceske Budejovice, Czech Republic.
authors.forename: J
authors.initials: J
authors.lastname: Horazdovsky
authors.affiliation: Department of Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
authors.forename: E
authors.initials: E
authors.lastname: Sticova
authors.affiliation: Department of Dermatovenereology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
authors.forename: A
authors.initials: A
authors.lastname: Fialova
authors.affiliation: Department of Dermatovenereology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
authors.forename: P
authors.initials: P
authors.lastname: Arenberger
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001706:Biopsy; D005260:Female; D006801:Humans; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D000077594:Nivolumab / Q000494:pharmacology*; D012535:Scalp; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis / Q000209:etiology*; D017211:Treatment Failure; D000077484:Vemurafenib / Q000009:adverse effects* / Q000627:therapeutic use; D000096142:Cutaneous Malignant Melanoma
chemical_list: D000970:Antineoplastic Agents; D000077484:Vemurafenib; D000077594:Nivolumab